DexCom, a leading manufacturer of continuous glucose monitoring systems, is confronting one of the most significant ...
Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...
Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...
Dexcom Inc. received U.S. FDA clearance for its Smart Basal CGM-integrated basal insulin dosing optimizer. Designed for adults with type 2 diabetes using glargine U-100 long-acting insulin therapy, ...
Zacks Investment Research on MSN
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal
DexCom DXCM recently announced that it has received FDA clearance for its CGM-integrated basal insulin dosing optimizer, ...
CNET on MSN
Oura Rings Will Soon Work With Dexcom to Connect the Dots Between Activity, Food and Blood Sugar
Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...
Dexcom (NSDQ:DXCM) announced today that it plans to launch its G7 15 Day continuous glucose monitor (CGM) in the U.S. next ...
Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer.
Home Care Delivered doesn’t mention big changes in federal funding of health care in the company’s announcement of 73 layoffs at its corporate office in Henrico County.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback